Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 4/20 | 0.44 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | LMNA | P02545 | 3/20 | 0.34 |
| ▸ | CA12 | O43570 | 2/20 | 0.34 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.34 |
| ▸ | RECQL | P46063 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.33 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | HTT | P42858 | 1/20 | 0.33 |
| ▸ | MGAM | O43451 | 1/20 | 0.32 |
| ▸ | GAA | P10253 | 1/20 | 0.32 |
| ▸ | SI | P14410 | 1/20 | 0.32 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.32 |
| ▸ | TET2 | Q6N021 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10085341 | 0.91 | TSHR (0.47) | TSHRHSD17B10KMT2AMEN1LMNA | |
| SCHEMBL10085230 | 0.83 | CYP1A2 (0.41) | TSHRKMT2AMEN1LMNAKDM4E | |
| SCHEMBL1665311 | 0.82 | TSHR (0.36) | TSHRHSD17B10KMT2AMEN1KDM4E | |
| SCHEMBL6891006 | 0.80 | TSHR (0.42) | TSHRHSD17B10KMT2AMEN1LMNA | |
| SCHEMBL14566406 | 0.78 | MEN1 (0.33) | KMT2AMEN1ALDH1A1 | |
| SCHEMBL12149865 | 0.75 | RIPK1 (0.31) | KDM4E | |
| SCHEMBL17403974 | 0.74 | ACHE (0.38) | — | |
| SCHEMBL13522419 | 0.74 | RIPK1 (0.31) | — | |
| SCHEMBL12695618 | 0.74 | NOS3 (0.40) | HSD17B10ALDH1A1MAPT | |
| SCHEMBL9509274 | 0.73 | TSHR (0.55) | TSHRHSD17B10KMT2AMEN1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 125 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12371723-B2 | Variant LovD polypeptides and their uses | CODEXIS, INC. (US) | 2025-07-29 | — | — | US | disclosed |
| US-20240368649-A1 | LOV-D ACYLTRANSFERASE MEDIATED ACYLATION | CODEXIS INC (US) | 2024-11-07 | — | — | US | disclosed |
| US-12060592-B2 | Lov-D acyltransferase mediated acylation | CODEXIS, INC. (US) | 2024-08-13 | — | — | US | disclosed |
| US-20240218407-A1 | VARIANT LOVD POLYPEPTIDES AND THEIR USES | INNOVATUS LIFE SCIENCES LENDING FUND I, LP, AS COLLATERAL AGENT | 2024-07-04 | — | — | US | disclosed |
| US-20240218407-A1 | VARIANT LOVD POLYPEPTIDES AND THEIR USES | INNOVATUS LIFE SCIENCES LENDING FUND I, LP, AS COLLATERAL AGENT | 2024-07-04 | — | — | US | disclosed |
| US-20240218407-A1 | VARIANT LOVD POLYPEPTIDES AND THEIR USES | INNOVATUS LIFE SCIENCES LENDING FUND I, LP, AS COLLATERAL AGENT | 2024-07-04 | — | — | US | disclosed |
| US-11926857-B2 | Variant LovD polypeptides and their uses | CODEXIS, INC. (US) | 2024-03-12 | — | — | US | disclosed |
| US-20210277432-A1 | VARIANT LOVD POLYPEPTIDES AND THEIR USES | INNOVATUS LIFE SCIENCES LENDING FUND I, LP, AS COLLATERAL AGENT | 2021-09-09 | — | — | US | disclosed |
| US-20210277432-A1 | VARIANT LOVD POLYPEPTIDES AND THEIR USES | INNOVATUS LIFE SCIENCES LENDING FUND I, LP, AS COLLATERAL AGENT | 2021-09-09 | — | — | US | disclosed |
| US-11046982-B2 | Variant LovD polypeptides and their uses | CODEXIS, INC. (US) | 2021-06-29 | — | — | US | disclosed |
| EP-2032715-B1 | Methods and materials for making simvastatin and related compounds | UNIV CALIFORNIA (US) | 2012-02-01 | — | — | EP | disclosed |
| US-20110111468-A1 | VARIANT LOVD POLYPEPTIDES AND THEIR USES | CODEXIS, INC. (US) | 2011-05-12 | — | — | US | disclosed |
| US-20110111468-A1 | VARIANT LOVD POLYPEPTIDES AND THEIR USES | CODEXIS, INC. (US) | 2011-05-12 | — | — | US | disclosed |
| US-20110111468-A1 | VARIANT LOVD POLYPEPTIDES AND THEIR USES | CODEXIS, INC. (US) | 2011-05-12 | — | — | US | disclosed |
| WO-2011041231-A1 | VARIANT LOVD POLYPEPTIDES AND THEIR USES | CODEXIS, INC. (US) | 2011-04-07 | — | — | WO | disclosed |
| WO-2011041231-A1 | VARIANT LOVD POLYPEPTIDES AND THEIR USES | CODEXIS, INC. (US) | 2011-04-07 | — | — | WO | disclosed |
| WO-2011041233-A1 | IMPROVED LOV-D ACYLTRANSFERASE MEDIATED ACYLATION | CODEXIS, INC. (US) | 2011-04-07 | — | — | WO | disclosed |
| WO-2011041233-A1 | IMPROVED LOV-D ACYLTRANSFERASE MEDIATED ACYLATION | CODEXIS, INC. (US) | 2011-04-07 | — | — | WO | disclosed |
| US-20090191602-A1 | Methods and Materials for Making Simvastatin and Related Compounds | INNOVATUS LIFE SCIENCES LENDING FUND I, LP, AS COLLATERAL AGENT | 2009-07-30 | — | — | US | disclosed |
| US-20090191602-A1 | Methods and Materials for Making Simvastatin and Related Compounds | INNOVATUS LIFE SCIENCES LENDING FUND I, LP, AS COLLATERAL AGENT | 2009-07-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240368649-A1 | LOV-D ACYLTRANSFERASE MEDIATED ACYLATION | ACAT2, LCAT, ACOT7 | TSHR 4462/4885HSD17B10 118/4885KMT2A 579/4885 |
| US-11046982-B2 | Variant LovD polypeptides and their uses | LCAT, HMGCR, FNTA | TSHR 4500/4885HSD17B10 66/4885KMT2A 2211/4885 |
| US-12060592-B2 | Lov-D acyltransferase mediated acylation | ACAT2, LCAT, ACOT7 | TSHR 4462/4885HSD17B10 118/4885KMT2A 579/4885 |
| US-20210277432-A1 | VARIANT LOVD POLYPEPTIDES AND THEIR USES | LCAT, HMGCR, FNTA | TSHR 4500/4885HSD17B10 66/4885KMT2A 2211/4885 |
| US-11926857-B2 | Variant LovD polypeptides and their uses | LCAT, HMGCR, FNTA | TSHR 4500/4885HSD17B10 66/4885KMT2A 2211/4885 |
| US-20110111468-A1 | VARIANT LOVD POLYPEPTIDES AND THEIR USES | PCSK9, HMGCR, LCAT | TSHR 4517/4885HSD17B10 67/4885KMT2A 2868/4885 |
| US-20240218407-A1 | VARIANT LOVD POLYPEPTIDES AND THEIR USES | LCAT, HMGCR, FNTA | TSHR 4500/4885HSD17B10 66/4885KMT2A 2211/4885 |
| US-12371723-B2 | Variant LovD polypeptides and their uses | LCAT, HMGCR, FNTA | TSHR 4500/4885HSD17B10 66/4885KMT2A 2211/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.